Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 68462-435

3 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 68462-435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lbl333mg180

Lbl333mg180
Acamprosate Calcium 333 mg delayed-release tablets packaging label by Glenmark Pharmaceuticals Inc., USA. The label indicates 180 tablets per container, oral route, prescription only, with storage and handling instructions noted. The NDC number 68462-435 is displayed with barcode and lot information.*
FDA Label Image
Logo
FDA Label Image

Structure

Structure
Chemical structure of Acamprosate Calcium, showing the molecular arrangement including the acetyl, amino, and sulfonate groups complexed with calcium ions (Ca2+).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.